scispace - formally typeset
N

Nikki Smith

Researcher at University of Sheffield

Publications -  11
Citations -  4801

Nikki Smith is an academic researcher from University of Sheffield. The author has contributed to research in topics: Subgenomic mRNA & Medicine. The author has an hindex of 7, co-authored 9 publications receiving 2675 citations. Previous affiliations of Nikki Smith include Imperial College London.

Papers
More filters
Journal ArticleDOI

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

Merryn Voysey, +766 more
- 06 Mar 2021 - 
TL;DR: The ChAdOx1 nCoV-19 (AZD1222) vaccine has been approved for emergency use by the UK regulatory authority, Medicines and Healthcare products Regulatory Agency, with a regimen of two standard doses given with an interval of 4-12 weeks as discussed by the authors.
Journal ArticleDOI

Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study.

Katherine A Twohig, +607 more
TL;DR: In this paper, the authors compared the severity of the delta variant compared with the alpha variant by determining the relative risk of hospital attendance outcomes and found that outbreaks of the Delta variant in unvaccinated populations might lead to a greater burden on health-care services than the alpha variants.
Journal ArticleDOI

Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant.

Paul Elliott, +592 more
- 02 Nov 2021 - 
TL;DR: In this article, the authors assessed RT-PCR swab-positivity in the REAL-time Assessment of Community Transmissibility (RACT) in many countries associated with the Delta variant.